期刊文献+

CEP65在肝癌中的表达及其对肝癌细胞迁移、侵袭的影响

The expression of CEP65 in hepatocellular carcinoma and its significance in inhibiting migration and invasion
下载PDF
导出
摘要 目的:探讨肿瘤及胚胎组织特异表达蛋白65(cancer and embryo expression protein 65,CEP65)在肝癌组织中的表达,分析siRNA干扰CEP65后对肝癌细胞迁移及侵袭的影响。方法:免疫组化法检测肝癌组织中CEP65的表达情况;Western blot法检测CEP65在肝癌细胞中的表达水平,并通过siRNA干扰CEP65后Transwell实验检测敲低CEP65表达后对肝癌细胞迁移及侵袭的影响。结果 :CEP65在肝癌组织中的表达明显高于癌旁组织;肝癌组织中CEP65高表达与TNM分期、门静脉侵犯及Edmondson分级显著相关;高表达CEP65患者5年生存率明显低于CEP65低表达组;siRNA干扰肝癌MHCC-97H细胞CEP65的表达后可显著抑制其迁移及侵袭。结论:CEP65在肝癌组织中的表达明显升高,并促进肝癌细胞迁移及侵袭。 Objective: To investigate the expression of CEP65 in hepatocellular carcinoma( HCC) patients and explore its role in migration and invasion of HCC cells through RNA interference. Methods: The expression of CEP65 in HCC tissues was assessed by immunohistochemistry. The expression level of CEP65 was determined by Western blot.The effect of CEP65 knockdown by siRNA on migration and invasion of HCC cell was observed by Transwell assay.Results:CEP65 expression was significantly highly expressed in HCC tissues compared to tumor- adjacent tissue. Its high expression was significantly associated with TNM stage,portal vein infiltration and Edmondson degree. Patients in the high CEP65 group had a lower 5- year survival than those in low CEP65 group. Down- regulated of CEP65 by siRNA could inhibit cell migration and invasion in MHCC- 97 H cell. Conclusion:The expression of CEP65 in HCC increased significantly,and it contributes to the migration and invasion of HCC cells.
出处 《现代肿瘤医学》 CAS 2017年第4期590-594,共5页 Journal of Modern Oncology
基金 西安医学院附属医院科研项目(编号:XYFY-09-27)
关键词 肝癌 CEP65 迁移 侵袭 hepatocellular carcinoma CEP65 migration invasion
  • 相关文献

参考文献4

二级参考文献25

  • 1Nobuhisa Akamatsu,Yasuhiko Sugawara,Norihiro Kokudo.Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma[J].World Journal of Hepatology,2014,6(9):626-631. 被引量:13
  • 2寿成超,李彩凤,孟麟,董志伟.抗胃癌单链抗体的构建、表达及活性测定[J].中华医学杂志,1997,77(6):434-438. 被引量:7
  • 3Toshimi Kaido,Kohei Ogawa,Akira Mori,Yasuhiro Fujimoto,Takashi Ito,Koji Tomiyama,Yasutsugu Takada,Shinji Uemoto.Usefulness of Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma[J].Surgery.2013
  • 4Zi Yin,Xinxiang Fan,Hua Ye,Dong Yin,Jie Wang.Short- and Long-term Outcomes after Laparoscopic and Open Hepatectomy for Hepatocellular Carcinoma: A Global Systematic Review and Meta-analysis[J].Annals of Surgical Oncology.2013(4)
  • 5Giovanni Vennarecci,Andrea Laurenzi,Roberto Santoro,Marco Colasanti,Pasquale Lepiane,Giuseppe Maria Ettorre.The ALPPS Procedure: A Surgical Option for Hepatocellular Carcinoma with Major Vascular Invasion[J]. World Journal of Surgery . 2014 (6)
  • 6G. Vennarecci,A. Laurenzi,G.B. Levi Sandri,E. Busi Rizzi,M. Cristofaro,M. Montalbano,P. Piselli,A. Andreoli,G. D’Offizi,G.M. Ettorre.The ALPPS procedure for hepatocellular carcinoma[J]. European Journal of Surgical Oncology . 2014
  • 7Welzel TM,Graubard BI,Zeuzem S,El-Serag HB,Davila JA,McGlynn KA.Metabolic syndrome increases the risk of primary liver cancer in the United States:a study in the SEER-Medicare database. Hepatology . 2011
  • 8Man Yang,Jin-Qiu Yuan,Ming Bai,Guo-Hong Han.Transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis[J]. Molecular Biology Reports . 2014 (10)
  • 9Zhenyin Liu,Fei Gao,Guang Yang,Sristi Singh,Mingjian Lu,Tao Zhang,Zhihui Zhong,Fujun Zhang,Rijie Tang.Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis[J]. Tumor Biology . 2014 (8)
  • 10Yingmei Zhang,Dongbo Xu,Xiaochun Wang,Ming Lu,Bo Gao,Xin Qiao.Screening of kinase inhibitors targeting BRAF for regulating autophagybased on kinase pathways[J]. Molecular Medicine Reports . 2014 (1)

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部